Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 373 entries
View as:

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

Phase: N/A Priority: Normal
NCT ID: NCT01546909 Org: User:
Start: 02/29/12 End: 12/31/12 Due: 12/31/13

Repeated Cross Sectional Surveillance Study To Determine the Respiratory Syncytial Virus (RSV) Immunization Rates in German Infants

Phase: N/A Priority: Normal
NCT ID: NCT06824207 Org: User:
Start: 01/13/25 End: 05/30/26 Due: 05/30/27

Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry

Phase: N/A Priority: Normal
NCT ID: NCT02554409 Org: User:
Start: 10/13/15 End: 04/30/19 Due: 04/30/20

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland

Phase: N/A Priority: Normal
NCT ID: NCT04594551 Org: User:
Start: 10/11/20 End: 06/23/21 Due: 06/23/22

Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00554333 Org: User:
Start: 10/31/07 End: 12/31/07 Due: 12/31/08

Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation

Phase: N/A Priority: Normal
NCT ID: NCT00946179 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

Post Marketing Surveillance for ADACEL™ in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT01137435 Org: User:
Start: 06/30/10 End: 09/30/16 Due: 09/30/17

Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly

Phase: N/A Priority: Normal
NCT ID: NCT00885157 Org: User:
Start: 04/30/09 End: 12/31/09 Due: 12/31/10

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)

Phase: N/A Priority: Normal
NCT ID: NCT01691326 Org: User:
Start: 09/30/12 End: 02/28/13 Due: 02/28/14

Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT06582056 Org: User:
Start: 10/09/24 End: 07/31/25 Due: 07/31/26

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01946438 Org: User:
Start: 09/30/13 End: 07/31/14 Due: 07/31/15

Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT02539108 Org: User:
Start: 08/31/15 End: 07/31/16 Due: 07/31/17

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico

Phase: N/A Priority: Normal
NCT ID: NCT03630705 Org: User:
Start: 10/17/18 End: 02/18/22 Due: 02/18/23

Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT05829356 Org: User:
Start: 04/12/23 End: 03/14/24 Due: 03/14/25

Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00348881 Org: User:
Start: 06/30/06 End: 06/30/08 Due: 06/30/09

Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US

Phase: N/A Priority: Normal
NCT ID: NCT03282240 Org: User:
Start: 09/08/17 End: 04/19/18 Due: 04/19/19

A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00491257 Org: User:
Start: 06/30/07 End: 07/31/07 Due: 07/31/08

A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT02553343 Org: User:
Start: 09/30/15 End: 04/04/16 Due: 04/04/17

Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)

Phase: N/A Priority: Normal
NCT ID: NCT05687279 Org: User:
Start: 02/06/23 End: 12/27/24 Due: 12/27/25

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT05650554 Org: User:
Start: 12/12/22 End: 04/02/24 Due: 04/02/25

Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT02915302 Org: User:
Start: 09/23/16 End: 03/06/17 Due: 03/06/18

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

Phase: N/A Priority: Normal
NCT ID: NCT00282581 Org: User:
Start: 10/31/06 End: 07/31/07 Due: 07/31/08

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT06686654 Org: User:
Start: 11/11/24 End: 09/02/27 Due: 09/02/28

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants

Phase: N/A Priority: Normal
NCT ID: NCT00831753 Org: User:
Start: 05/31/08 End: 11/30/09 Due: 11/30/10

Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT01890759 Org: User:
Start: 06/25/13 End: 04/12/16 Due: 04/12/17